文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

儿童脑肿瘤患者放射性垂体损伤的预测因素

Predictive factors for radiation-induced pituitary damage in pediatric patients with brain tumors.
PubMed 文献 · Radiother Oncol · 2024-04-18

该回顾性分析纳入2002至2018年诊断的193例儿童脑肿瘤患者(54.9%为男性),随访至少两年,于诊断时及诊断后2、5、10年用MRI测量垂体高度。放疗是所有观察时间点垂体高度降低的显著预测因素,化疗或放疗史及10年时垂体高度是内分泌缺乏的预测因素;作者建议对儿童脑肿瘤幸存者的监测影像评估垂体,若小于同龄应有水平则行内分泌评估。

要点

  • 放疗是儿童脑肿瘤患者所有观察时间点垂体高度降低的显著预测因素(p=0.016、p<0.001、p=0.008)。
  • 化疗史(p=0.004)、放疗史(p=0.022)及10年时垂体高度(p=0.047)是内分泌缺乏的预测因素。
  • 作者建议对儿童脑肿瘤幸存者的监测影像评估垂体,若小于同龄应有水平则行临床内分泌评估。

核心结论

  • 儿童颅脑照射与垂体生理性增大受损相关,而垂体高度降低又与内分泌功能障碍相关。
  • 作者建议对儿童脑肿瘤幸存者的监测影像评估垂体,若小于同龄应有水平则行临床内分泌评估。

研究设计与样本

  • 回顾性分析纳入2002至2018年诊断的193例儿童脑肿瘤患者(54.9%为男性),要求至少两年影像学随访。
  • 于诊断时及诊断后2、5、10年用MRI测量垂体高度,临床数据来自患者病历。

主要发现

  • 诊断时平均年龄7.6±4.5岁,随访6.1±3.4年;52.8%接受放疗,37.8%出现垂体激素缺乏。
  • 放疗是所有观察时间点垂体高度降低的显著预测因素(p=0.016、p<0.001、p=0.008)。
  • 化疗史(p=0.004)、放疗史(p=0.022)及10年时垂体高度(p=0.047)是内分泌缺乏的预测因素。
  • 方差分析显示儿童垂体高度随时间预期增加,但该增长受放疗和性别显著影响(交互作用p=0.005和p=0.025)。

临床怎么用

  • 作者建议对儿童脑肿瘤幸存者的监测影像评估垂体,若小于同龄应有水平则行临床内分泌评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Multiple studies demonstrated hypothalamic-pituitary dysfunction in survivors of pediatric brain tumors. However, few studies investigated the trajectories of pituitary height in these patients and their associations with pituitary function. We aimed to evaluate longitudinal changes of pituitary height in children and adolescents with brain tumors, and their association with endocrine deficiencies. MATERIALS AND METHODS: We conducted a retrospective analysis of 193 pediatric patients (54.9% male) diagnosed with brain tumors from 2002 to 2018, with a minimum of two years of radiological follow-up. Pituitary height was measured using MRI scans at diagnosis and at 2, 5, and 10 years post-diagnosis, with clinical data sourced from patient charts. RESULTS: Average age at diagnosis was 7.6 ± 4.5 years, with a follow-up of 6.1 ± 3.4 years. 52.8% underwent radiotherapy and 37.8% experienced pituitary hormone deficiency. Radiation treatment was a significant predictor of decreased pituitary height at all observed time points (p = 0.016, p < 0.001, p = 0.008, respectively). Additionally, chemotherapy (p = 0.004) or radiotherapy (p = 0.022) history and pituitary height at 10 years (p = 0.047) were predictors of endocrine deficiencies. ANOVA revealed an expected increase in pituitary height over time in pediatric patients, but this growth was significantly impacted by radiation treatment and gender (p for interaction = 0.005 and 0.025, respectively). CONCLUSION: Cranial irradiation in pediatric patients is associated with impairment of the physiologic increase in pituitary size; in turn, decreased pituitary height is associated with endocrine dysfunction. We suggest that pituitary gland should be evaluated on surveillance imaging of pediatric brain tumor survivors, and if small for age, clinical endocrine evaluation should be pursued.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Gorenstein L, Shrot S, Ben-Ami M, et al. Predictive factors for radiation-induced pituitary damage in pediatric patients with brain tumors. Radiother Oncol. 2024. PMID: 38641261. doi:10.1016/j.radonc.2024.110268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。